[go: up one dir, main page]

WO2023081377A3 - Compositions comprising an rna guide targeting ciita and uses thereof - Google Patents

Compositions comprising an rna guide targeting ciita and uses thereof Download PDF

Info

Publication number
WO2023081377A3
WO2023081377A3 PCT/US2022/048989 US2022048989W WO2023081377A3 WO 2023081377 A3 WO2023081377 A3 WO 2023081377A3 US 2022048989 W US2022048989 W US 2022048989W WO 2023081377 A3 WO2023081377 A3 WO 2023081377A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
rna guide
sequence
ciita
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2022/048989
Other languages
French (fr)
Other versions
WO2023081377A2 (en
Inventor
Quinton Norman WESSELLS
Tia Marie DITOMMASO
Jeffrey Raymond HASWELL
Noah Michael Jakimo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arbor Biotechnologies Inc
Original Assignee
Arbor Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Biotechnologies Inc filed Critical Arbor Biotechnologies Inc
Publication of WO2023081377A2 publication Critical patent/WO2023081377A2/en
Publication of WO2023081377A3 publication Critical patent/WO2023081377A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to compositions comprising RNA guides targeting CIITA, processes for characterizing the compositions, cells comprising the compositions, and methods of using the compositions. The invention provides a composition comprising an RNA guide, wherein the RNA guide comprises (i) a spacer sequence that is substantially complementary to a target sequence within a CIITA gene and (ii) a direct repeat sequence; wherein the target sequence is adjacent to a protospacer adjacent motif (PAM) comprising the sequence 5 '-NTTN-3'.
PCT/US2022/048989 2021-11-05 2022-11-04 Compositions comprising an rna guide targeting ciita and uses thereof Ceased WO2023081377A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163276229P 2021-11-05 2021-11-05
US63/276,229 2021-11-05
US202163294121P 2021-12-28 2021-12-28
US63/294,121 2021-12-28

Publications (2)

Publication Number Publication Date
WO2023081377A2 WO2023081377A2 (en) 2023-05-11
WO2023081377A3 true WO2023081377A3 (en) 2023-09-14

Family

ID=86242120

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2022/048989 Ceased WO2023081377A2 (en) 2021-11-05 2022-11-04 Compositions comprising an rna guide targeting ciita and uses thereof

Country Status (2)

Country Link
TW (1) TW202334421A (en)
WO (1) WO2023081377A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021158918A1 (en) * 2020-02-05 2021-08-12 Danmarks Tekniske Universitet Compositions and methods for targeting, editing or modifying human genes
WO2021202800A1 (en) * 2020-03-31 2021-10-07 Arbor Biotechnologies, Inc. Compositions comprising a cas12i2 variant polypeptide and uses thereof
WO2023039534A2 (en) * 2021-09-10 2023-03-16 Arbor Biotechnologies, Inc. Compositions comprising a cas12i polypeptide and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021158918A1 (en) * 2020-02-05 2021-08-12 Danmarks Tekniske Universitet Compositions and methods for targeting, editing or modifying human genes
WO2021202800A1 (en) * 2020-03-31 2021-10-07 Arbor Biotechnologies, Inc. Compositions comprising a cas12i2 variant polypeptide and uses thereof
WO2023039534A2 (en) * 2021-09-10 2023-03-16 Arbor Biotechnologies, Inc. Compositions comprising a cas12i polypeptide and uses thereof

Also Published As

Publication number Publication date
WO2023081377A2 (en) 2023-05-11
TW202334421A (en) 2023-09-01

Similar Documents

Publication Publication Date Title
CA3174139A1 (en) Rna-editing compositions and methods of use
WO2023283642A3 (en) Pan-human coronavirus concatemeric vaccines
GB0921949D0 (en) Curable compositions and membranes
CR20230413A (en) Modulators of sting (stimulator of interferon genes)
GB0921951D0 (en) Curable compositions and membranes
AU2021216418A8 (en) Compositions and methods for targeting, editing or modifying human genes
WO2022162027A3 (en) Method of reducing the immunostimulatory properties of in vitro transcribed rna
WO2022187288A3 (en) Systems and methods for genome-wide annotation of gene regulatory elements linked to cell fitness
WO2021032777A8 (en) Oligonucleotide conjugate compositions and methods of use
WO2023178144A3 (en) Galnac compositions for improving sirna bioavailability
WO2023081377A3 (en) Compositions comprising an rna guide targeting ciita and uses thereof
CO2021014015A2 (en) Gene editing systems for modifying a scn9a or scn10a gene and methods for their use
WO2024187190A3 (en) Compositions and methods for inhibition of expression of inhibin subunit beta e (inhbe) genes
WO2021231263A3 (en) Nucleic acid amplification methods
WO2023213983A3 (en) Expression construct
WO2023245126A3 (en) Products and compositions
WO2023107946A3 (en) Omni-103 crispr nuclease-rna complexes
CA3249102A1 (en) Targeting ligand and use thereof
WO2022266538A3 (en) Compositions and methods for targeting, editing or modifying human genes
WO2022256642A3 (en) Gene editing systems comprising an rna guide targeting hydroxyacid oxidase 1 (hao1) and uses thereof
MX2024013951A (en) COMPOSITIONS AND METHODS FOR INHIBITING <i>MAPT </i>EXPRESSION
WO2022118016A3 (en) Enzyme inhibitors
WO2023230557A3 (en) Mobile genetic elements from eptesicus fuscus
WO2022189690A3 (en) Use of a composition obtained from microorganisms
WO2021243267A3 (en) Compositions comprising a cas12i2 polypeptide and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22890832

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 22890832

Country of ref document: EP

Kind code of ref document: A2